Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | BAD | Q92934 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | DRD5 | P21918 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | HPN | P05981 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2150662 | 0.94 | BCL2L1 (0.45) | BCL2L1BADDRD2DRD3DRD1 | |
| Acetic Acid SCHEMBL11352341 | 0.88 | BCL2L1 (0.41) | BCL2L1BADDRD2DRD3DRD1 | |
| Isopropylamine SCHEMBL11669368 | 0.88 | BCL2L1 (0.41) | BCL2L1BADDRD2DRD3DRD1 | |
| SCHEMBL3962200 | 0.81 | BCL2L1 (0.50) | BCL2L1BADDRD2DRD3DRD1 | |
| SCHEMBL8676261 | 0.73 | PIM1 (0.35) | BCL2L1BADALDH1A1ALOX15HSD17B10 | |
| SCHEMBL16772449 | 0.73 | AURKA (0.33) | ALDH1A1ALOX15HSD17B10TDP1MEN1 | |
| SCHEMBL21092188 | 0.71 | DRD2 (0.33) | DRD2DRD1ALDH1A1ALOX15HSD17B10 | |
| SCHEMBL11788924 | 0.71 | CYP1A2 (0.36) | BCL2L1BADALDH1A1TSHRCA1 | |
| SCHEMBL8527304 | 0.71 | CD44 (0.44) | ALDH1A1ALOX15HSD17B10TDP1MEN1 | |
| SCHEMBL19011783 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013083582-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | claimed |
| JP-3081238-A | — | — | None | — | — | JP | disclosed |
| EP-3838900-B1 | 3-ARYLOXY-3-ARYL-PROPYLAMINE COMPOUND AND USES THEREOF | ZHANGZHOU PIEN TZE HUANG PHARM (CN) | 2025-02-12 | — | — | EP | disclosed |
| US-20250019593-A1 | RENEWABLE DIESEL PRODUCTION FROM CATALYTIC PYROLYSIS FEEDSTOCK | IFP Energies Nouvelles (FR) | 2025-01-16 | — | — | US | disclosed |
| US-20250011655-A1 | RENEWABLE JET PRODUCTION FROM CATALYTIC PYROLYSIS FEEDSTOCK | IFP Energies Nouvelles (FR) | 2025-01-09 | — | — | US | disclosed |
| US-20240336588-A1 | COMPOSITIONS AND METHODS FOR ANTIOXIDANT AND ANTI-INFLAMMATORY THERAPEUTICS | AVANTI BIOSCIENCES, INC. | 2024-10-10 | — | — | US | disclosed |
| EP-4433552-A1 | RENEWABLE DIESEL PRODUCTION FROM CATALYTIC PYROLYSIS FEEDSTOCK | IFP Energies nouvelles (FR) | 2024-09-25 | — | — | EP | disclosed |
| EP-4433553-A1 | RENEWABLE JET PRODUCTION FROM CATALYTIC PYROLYSIS FEEDSTOCK | IFP Energies nouvelles (FR) | 2024-09-25 | — | — | EP | disclosed |
| CN-115611708-B | Preparation method of rotigotine impurity K | 北京福元医药股份有限公司沧州分公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-118302504-A | Preparation of renewable jet fuel from catalytic pyrolysis feedstock | IFP 新能源公司 | 2024-07-05 | — | — | CN | disclosed |
| US-4265911-A | Propionamidoxime derivatives | SYNTHELABO (FR) | 1981-05-05 | — | — | US | disclosed |
| US-4156789-A | INTERMEDIATES, ANTIFIBRILLATORY AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1979-05-29 | — | — | US | disclosed |
| US-4082773-A | TRICYCLIC TETRAHYDRO NAPHTHALENEOLS AND RELATED COMPOUNDS | E. R. SQUIBB & SONS, INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-4029676-A | ANTIADRENERGIC, ANTIFIBRILLATORY | E. R. SQUIBB & SONS, INC. (US) | 1977-06-14 | — | — | US | disclosed |
| US-4003930-A | 2,3-Trans-5-[3-(amino)-2-hydroxy-propoxy]-1,2,3,4-tetrahydro-3-(or 2)-amino-2-(or 3)-hydroxy-naphthalenes and salts thereof | E. R. SQUIBB & SONS, INC. (US) | 1977-01-18 | — | — | US | disclosed |
| US-3982021-A | Compositions for the treatment of coronary diseases containing tetrahydronaphthyloxy-aminopropanols | E. R. SQUIBB & SONS, INC. (US) | 1976-09-21 | — | — | US | disclosed |
| US-3969392-A | PARASITICIDE, BACTERICIDE, ANTIINFLAMMATORY, SURFACTANT | E. R. SQUIBB & SONS, INC. (US) | 1976-07-13 | — | — | US | disclosed |
| US-3956285-A | CORONARY DISEASES, WATER SOFTENERS, CORROSION INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1976-05-11 | — | — | US | disclosed |
| US-3943149-A | HYPOCHOLESTEREMIC, ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1976-03-09 | — | — | US | disclosed |
| US-3935267-A | CARDIOVASCULAR DISORDERS | E. R. SQUIBB & SONS, INC. (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336588-A1 | COMPOSITIONS AND METHODS FOR ANTIOXIDANT AND ANTI-INFLAMMATORY THERAPEUTICS | MPO, GPX4, GPX1 | BCL2L1 676/4885BAD 1575/4885DRD2 3074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.